Skip to main content
Signal8

Opipari Anthony W.

SEC insider (Form 3/4/5 filer). CIK 0002131341. Officer at Odyssey Therapeutics, Inc. (ODTX). 5 reported Form 4/5 transactions since Sep 2024; latest on May 11, 2026. Located in BOSTON, MA.

Companies Opipari Anthony W. has filed insider reports for

  • Odyssey Therapeutics, Inc. (ODTX): Officer, See Remarks
Opipari Anthony W. profile photo

Opipari Anthony W.

CIK: 0002131341

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Odyssey Therapeutics, Inc. logo
ODTX

Odyssey Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Odyssey Therapeutics, Inc. logo
    ODTX

    Odyssey Therapeutics, Inc.

    May 11, 2026
    Conversion
    Direct
    7K shares-
  • Odyssey Therapeutics, Inc. logo
    ODTX

    Odyssey Therapeutics, Inc.

    May 11, 2026
    Exercise
    Direct
    541 shares-
  • Odyssey Therapeutics, Inc. logo
    ODTX

    Odyssey Therapeutics, Inc.

    May 11, 2026
    Tax Payment
    Direct
    4 shares at avg. $18.00$72
  • Odyssey Therapeutics, Inc. logo
    ODTX

    Odyssey Therapeutics, Inc.

    May 7, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    250.2K shares-
  • Odyssey Therapeutics, Inc. logo
    ODTX

    Odyssey Therapeutics, Inc.

    May 7, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    27.8K shares-

1-5 of 5